Targeted Treatment for Blood Cancers With Calquence 100mg Capsule

The Calquence capsule consists of a second-generation Bruton’s tyrosine kinase (BTK) inhibitor called acalabrutinib.

Targeted Treatment for Blood Cancers With Calquence 100mg Capsule
Calquence 100 mg Capsule

Blood cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) result from the abnormal growth of white blood cells. However, the advent of targeted therapy has revolutionized the treatment approach by focusing on a specific pathway responsible to develop cancer, in contrast to treating the entire body. Calquence 100 mg Capsule is an innovative targeted therapy for the management of particular types of blood cancers, ensuring effective disease management with improved tolerability compared to conventional chemotherapy.

What Is Calquence 100 mg Capsule?  

The Calquence capsule consists of a second-generation Bruton’s tyrosine kinase (BTK) inhibitor called acalabrutinib. It is an oral anticancer drug used for the management of adult patients with particular B-cell malignancies. Calquence has been developed to offer targeted inhibition of cancer cell signaling with minimal off-target toxicity, as observed with first-generation BTK inhibitors.

Mechanism of Action  

It selectively inhibits the function of Bruton’s tyrosine kinase (BTK), which is a crucial enzyme participating in the survival, activation, and proliferation of abnormal cells. The inhibition of the function of BTK will prevent the survival signal from being transmitted, thereby inhibiting the proliferation of cancer cells and controlling the disease with minimal toxicity to normal cells.   

Uses of The Capsule  

It is usually used in the treatment of:

  • Chronic lymphocytic leukemia (CLL)

  • Small lymphocytic lymphoma (SLL)

  • Mantle cell lymphoma (MCL) after previous treatment

The choice of treatment depends on the stage of the disease, previous treatments, and the patient’s health status.

Some Possible Side Effects  

Although Calquence is more tolerable than traditional chemotherapy, some side effects can be experienced. Some of the common side effects include:

  • Headache

  • Diarrhea

  • Fatigue

  • Muscle or joint pain

  • Upper respiratory tract infections

Some possible but serious side effects may include:

  • Bleeding tendency

  • Heartbeat irregularities

  • Low blood cell count

  • Severe infections

The patient should seek immediate attention for any unusual bleeding, fever, or heart symptoms.

Precautions and Warnings  

Before taking the medication, the patient should inform the doctor about:

  • Bleeding disorders

  • Heart conditions or irregular heartbeat

  • Liver conditions

  • Current infections

The patient should avoid taking Calquence with strong acid-reducing agents unless instructed otherwise by a healthcare provider.

Conclusion  

This Capsule is a significant leap forward in the management of B-cell malignancies of the blood. For patients seeking Calquence 100mg Capsule for treatment of chronic lymphocytic leukemia and mantle cell lymphoma in India, it is essential to select a reliable supplier. At Globans Pharma, we are committed to making quality cancer medications available to patients while also being with them throughout their journey.

FAQs  

Is it a type of chemotherapy?

No, it is targeted therapy and not chemotherapy.

Is regular monitoring required during treatment?

Yes, regular blood tests and assessments are required for safe use.